Fulcrum Therapeutics Inc. (NASDAQ: FULC) reported Q3 EPS of ($0.31), $0.02 worse than the analyst estimate of ($0.29).

For earnings history and earnings-related data on Fulcrum Therapeutics Inc. (FULC) click here.